“The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition”, jkcvhl, vol. 4, no. 2, pp. 10–18, May 2017, doi: 10.15586/jkcvhl.2017.69.